8-K: Sleep Number Appoints Amy O'Keefe as CFO

Sentiment:

Executive Appointment and Strategic Update


Sleep Number Corporation announced the appointment of Amy O'Keefe as its new Chief Financial Officer, effective December 8, 2025, while reaffirming its full year 2025 financial guidance.

Capital raiseThe company's investor presentation states, "With expected improvements in financial results from the turnaround, the company is positioned to restructure the balance sheet with longer-duration debt to drive long-term shareholder value creation."The amended and extended credit agreement through 2027 provides financial flexibility, which could precede or facilitate a broader balance sheet restructuring.

Summary

  • Sleep Number Corporation appointed Amy K. O'Keefe as Executive Vice President and Chief Financial Officer, effective December 8, 2025.
  • Ms. O'Keefe succeeds Robert P. Ryder, who served as interim CFO and will transition to an advisory role until December 12, 2025.
  • Ms. O'Keefe brings over 30 years of experience in financial and operational transformations across consumer products, technology, and wellness sectors, including previous CFO roles at Avaya, Weight Watchers International, and Drive DeVilbiss Healthcare.
  • The company reaffirmed its full year 2025 financial guidance for net sales, adjusted EBITDA, year-end profitability exit rate, and compliance with revised loan covenants, including in the fourth quarter of 2025.
  • An updated investor presentation was released, detailing the "Sleep Number Shifts" turnaround strategy focused on repositioning the brand, expanding customer reach, and reigniting growth.
  • Key actions taken since April 2025 include over $135 million in cost reductions compared to 2024 (excluding restructuring and non-recurring costs), operational streamlining, and an amended and extended credit agreement through 2027.
  • Ms. O'Keefe's compensation package includes an annual base salary of $625,000, a target annual incentive of 70% of base salary, and long-term incentive inducement grants totaling $1.8 million.

Sentiment

Score: 7

Explanation: The filing presents a positive outlook on the company's turnaround efforts, highlighted by the appointment of an experienced CFO, reaffirmation of financial guidance, significant cost reductions, and a clear strategic plan for future growth and cash flow generation. The tone is optimistic about stabilizing the business and achieving profitable growth, despite acknowledging the ongoing turnaround phase.

Positives

  • Appointment of an experienced CFO, Amy K. O'Keefe, with over 30 years of experience in financial and operational transformations across relevant sectors.
  • Reaffirmation of full year 2025 financial guidance, indicating performance is within expectations during the turnaround phase.
  • Successful implementation of over $135 million in cost reductions in 2025 compared to 2024 (excluding restructuring and non-recurring costs).
  • Secured an amended and extended credit agreement through 2027, providing financial flexibility for the turnaround strategy.
  • Anticipation of positive free cash flow generation in 2026 and beyond, expected to de-lever the balance sheet.
  • Strategic framework "Sleep Number Shifts" aims to reposition the brand, expand customer reach, and reignite growth, with a focus on simplified product offerings and modernized marketing.
  • The company expects to achieve approximately $40 million of additional annualized cost reductions in 2026.

Risks

  • The company's results could differ materially from forward-looking statements due to certain risks and uncertainties.
  • The most important risks and uncertainties are described in the company's filings with the Securities and Exchange Commission, including in Item 1A of its Annual Report on Form 10-K and other periodic reports.

Future Outlook

The company anticipates generating positive free cash flow in 2026 and beyond, which is expected to facilitate de-leveraging the balance sheet. A simpler and differentiated product offering in 2026 is projected to enhance shop-ability, conversion rates, margins, and overall efficiency. The company is positioned to restructure its balance sheet with longer-duration debt as financial results improve from the turnaround strategy. Sleep Number expects to realize approximately $40 million in additional annualized cost reductions in 2026 and aims for continued marketing efficiency gains.

Management Comments

  • "Since joining Sleep Number, we’ve taken decisive action to stabilize the business and position it for sustainable growth. Our strategy is clear and centered on our strong brand, differentiated products, and simplified operating model to deliver value for shareholders, customers, and team members." Linda Findley, President & CEO.
  • "We believe that Amy’s experience in driving profitability and operational excellence will be valuable to us as we move the business forward." Linda Findley, President & CEO.
  • "I am excited to join Sleep Number at such a pivotal time in its turnaround. With science-based sleep technology, highly differentiated products and broad brand recognition, Sleep Number has exceptional assets upon which to build." Amy O'Keefe, CFO.
  • "I look forward to partnering with Linda and the entire team to advance the significant work already done, strengthen the financial foundation and position the company for sustainable, profitable growth." Amy O'Keefe, CFO.
  • "I believe that our leaner cost structure will stabilize the business and our 2026 plans are achievable." Linda Findley, President & CEO.

Industry Context

The appointment of a seasoned CFO with extensive experience in consumer products, technology, and wellness sectors aligns with Sleep Number's strategic shift towards becoming a customer-centric sleep wellness company. The company's focus on operational streamlining, cost reductions, and an amended credit agreement reflects a broader industry trend among retailers and consumer brands facing economic pressures, aiming to stabilize finances and reposition for growth. The emphasis on differentiated products, modernized marketing, and expanded distribution channels is a common strategy to capture market share in a competitive retail landscape, particularly within the evolving health and wellness segment.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Executive Vice President and Chief Financial OfficerRobert P. Ryder (interim)Amy K. O'Keefe2025-12-08Appointment of permanent CFO to succeed interim CFO.

Stakeholder Impact

  • Shareholders: Potential for increased shareholder value through strategic transformation, cost reductions, and anticipated free cash flow generation. The appointment of an experienced CFO and reaffirmed guidance may instill confidence.
  • Employees: Streamlined organization and cost reductions have already impacted the workforce (implied by >$135M cost savings and "leaner cost structure"). The company mentions "3,200 mission-driven team members" with renewed passion.
  • Customers: Focus on repositioning the brand, expanding customer reach, and simplifying product offerings aims to improve customer experience and value.
  • Creditors: Amended and extended credit agreement provides stability, and anticipated free cash flow generation is expected to de-lever the balance sheet, positively impacting creditors.

Next Steps

  • Amy K. O'Keefe to assume CFO role on December 8, 2025.
  • Robert P. Ryder to serve in an advisory role until December 12, 2025.
  • Granting of Special RSU award on December 15, 2025.
  • 2026 deferral elections for Executive Deferral Plan by December 31, 2025.
  • Compensation Committee approval of 2026 AIP expected in February 2026.
  • Granting of 2026 RSU and PSU awards on March 15, 2026.
  • Launch of simpler and differentiated product offering in 2026.
  • Execution of additional distribution pilots in 2026.
  • Generation of positive free cash flow in 2026 and beyond.
  • Eligibility for annual Long-term Incentive awards beginning in March 2027.
  • Potential restructuring of the balance sheet with longer-duration debt.

Key Dates

DateDescription
2025-11-17Date of offer letter to Amy K. O'Keefe.
2025-11-21Offer of employment valid until this date.
2025-11-28Date of earliest event reported (CFO appointment).
2025-12-02Date of press release and investor presentation posting.
2025-12-08Effective date of Amy K. O'Keefe's appointment as CFO.
2025-12-12Robert P. Ryder's last day in an advisory role.
2025-12-15Anticipated grant date for $400,000 time-vested Special RSU award.
2025-12-31Deadline for 2026 deferral elections for the Executive Deferral Plan.
2026-03-15Anticipated grant date for $600,000 time-vested 2026 RSU award and $800,000 Performance Stock Unit (PSU) award.
2026-01-01Expected start of positive free cash flow generation.
2027-03-01Eligibility for annual Long-term Incentive (LTI) awards begins.
2027-12-31Extended maturity date of the bank agreement.
2028-12-31End of performance period for PSU award (fiscal years 2026 to 2028).

Recommendation

hold

The appointment of a highly experienced CFO and the reaffirmation of financial guidance are positive signals, suggesting the company is on track with its turnaround plan. Significant cost reductions and a clear strategic framework ("Sleep Number Shifts") provide a foundation for future improvement. However, the company is still in a 'turnaround' phase, and while positive free cash flow is anticipated for 2026, the full impact of the strategy and its execution risks are yet to be fully realized. The general nature of the risk disclosures (referencing 10-K) means specific new risks are not detailed here. Therefore, a 'hold' recommendation is appropriate as investors await further evidence of sustained profitable growth and successful balance sheet restructuring.

Keywords

Sleep Number, SNBR, CFO appointment, financial guidance, turnaround strategy, investor presentation, cost reduction, corporate governance, executive compensation, retail, sleep wellness, smart bed, Nasdaq

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.